De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Medartis Holding Beheer
Beheer criteriumcontroles 3/4
De CEO Medartis Holding's is Christoph Bronnimann, benoemd in Sep2019, heeft een ambtstermijn van 5.08 jaar. De totale jaarlijkse vergoeding van { bedraagt CHF 1.87M, bestaande uit 26.8% salaris en 73.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.27% van de aandelen van het bedrijf, ter waarde CHF 2.10M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.8 jaar en 3.5 jaar.
Belangrijke informatie
Christoph Bronnimann
Algemeen directeur
CHF 1.9m
Totale compensatie
| Percentage CEO-salaris | 26.8% |
| Dienstverband CEO | 5.1yrs |
| Eigendom CEO | 0.3% |
| Management gemiddelde ambtstermijn | 3.8yrs |
| Gemiddelde ambtstermijn bestuur | 3.5yrs |
Recente managementupdates
Recent updates
The Strong Earnings Posted By Medartis Holding (VTX:MED) Are A Good Indication Of The Strength Of The Business
Aug 27
Medartis Holding AG (VTX:MED) Doing What It Can To Lift Shares
Aug 21When Should You Buy Medartis Holding AG (VTX:MED)?
May 10Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation
Apr 11The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence
Feb 14Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around
Oct 24Is Medartis Holding (VTX:MED) A Risky Investment?
Oct 03Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 06Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)
Jun 21Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital
Jan 31Why Medartis Holding AG (VTX:MED) Could Be Worth Watching
Oct 30These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat
Sep 07When Should You Buy Medartis Holding AG (VTX:MED)?
Jul 29Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital
May 06At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?
Feb 08Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around
Jan 18We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt
Nov 10Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital
Sep 29Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital
Jun 08How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?
Mar 16We're Watching These Trends At Medartis Holding (VTX:MED)
Feb 09
Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain
Jan 04What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?
Nov 19Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CHF 4m |
| Mar 31 2024 | n/a | n/a | CHF 2m |
| Dec 31 2023 | CHF 2m | CHF 500k | CHF 619k |
| Sep 30 2023 | n/a | n/a | -CHF 3m |
| Jun 30 2023 | n/a | n/a | -CHF 7m |
| Mar 31 2023 | n/a | n/a | -CHF 6m |
| Dec 31 2022 | CHF 2m | CHF 500k | -CHF 6m |
| Sep 30 2022 | n/a | n/a | -CHF 3m |
| Jun 30 2022 | n/a | n/a | -CHF 241k |
| Mar 31 2022 | n/a | n/a | CHF 3m |
| Dec 31 2021 | CHF 3m | CHF 500k | CHF 7m |
| Sep 30 2021 | n/a | n/a | CHF 9m |
| Jun 30 2021 | n/a | n/a | CHF 12m |
| Mar 31 2021 | n/a | n/a | CHF 6m |
| Dec 31 2020 | CHF 2m | CHF 467k | -CHF 944k |
| Sep 30 2020 | n/a | n/a | -CHF 3m |
| Jun 30 2020 | n/a | n/a | -CHF 4m |
| Mar 31 2020 | n/a | n/a | -CHF 1m |
| Dec 31 2019 | CHF 782k | CHF 168k | CHF 2m |
Compensatie versus markt: De totale vergoeding ($USD 2.21M ) Christoph } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Swiss markt ($USD 1.53M ).
Compensatie versus inkomsten: De vergoeding van Christoph is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Christoph Bronnimann (58 yo)
5.1yrs
Tenure
CHF 1,866,937
Compensatie
Dr. Christoph Bronnimann is Chief Executive Officer at Medartis AG since September 2019. He has been the Chief Executive Officer and Member of Executive Management Board at Medartis Holding AG since Septem...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Member of Executive Management Board | 5.1yrs | CHF 1.87m | 0.27% CHF 2.1m | |
| Founder & Vice Chairman | 26.8yrs | CHF 291.97k | 41.41% CHF 321.7m | |
| CFO & Member of the Executive Management Board | 3.6yrs | geen gegevens | 0.029% CHF 227.1k | |
| VP of EMEA & Member of Executive Management Board | 4.2yrs | geen gegevens | 0.053% CHF 415.5k | |
| CTO & Member of the Executive Board | 3.9yrs | geen gegevens | 0.017% CHF 132.0k | |
| COO & Member of Management Board | 2.8yrs | geen gegevens | 0.0027% CHF 20.8k | |
| Chief Human Resources Officer & Executive Management Board Member | no data | geen gegevens | geen gegevens | |
| Head of Regulatory Affairs | 3.6yrs | geen gegevens | geen gegevens |
3.8yrs
Gemiddelde duur
55yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van MED wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder & Vice Chairman | 26.8yrs | CHF 291.97k | 41.41% CHF 321.7m | |
| Independent Non-Executive Director | 6.8yrs | CHF 188.29k | 0.19% CHF 1.5m | |
| Independent Chairman | 4.5yrs | CHF 568.06k | 0.065% CHF 505.7k | |
| Independent Director | 2.5yrs | CHF 112.76k | 0.0096% CHF 74.9k | |
| Independent Non Executive Director | 14.8yrs | CHF 161.68k | 4.55% CHF 35.3m | |
| Independent Non-Executive Director | less than a year | geen gegevens | geen gegevens | |
| Independent Non-Executive Director | less than a year | geen gegevens | geen gegevens | |
| Independent Director | 2.5yrs | CHF 171.53k | 0.0072% CHF 56.2k |
3.5yrs
Gemiddelde duur
60.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van MED wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).